← Back to search

Longitudinal assessment of tumor development using cancer avatars derived from genetically engineered pluripotent stem cells.

Nature communications · 2020 · Vol. 11 (1) · pp. 550

Abstract

Many cellular models aimed at elucidating cancer biology do not recapitulate pathobiology including tumor heterogeneity, an inherent feature of cancer that underlies treatment resistance. Here we introduce a cancer modeling paradigm using genetically engineered human pluripotent stem cells (hiPSCs) that captures authentic cancer pathobiology. Orthotopic engraftment of the neural progenitor cells derived from hiPSCs that have been genome-edited to contain tumor-associated genetic driver mutations revealed by The Cancer Genome Atlas project for glioblastoma (GBM) results in formation of high-grade gliomas. Similar to patient-derived GBM, these models harbor inter-tumor heterogeneity resembling different GBM molecular subtypes, intra-tumor heterogeneity, and extrachromosomal DNA amplification. Re-engraftment of these primary tumor neurospheres generates secondary tumors with features characteristic of patient samples and present mutation-dependent patterns of tumor evolution. These cancer avatar models provide a platform for comprehensive longitudinal assessment of human tumor development as governed by molecular subtype mutations and lineage-restricted differentiation.

Publication Types

["Journal Article"]

Keywords

[]

MeSH Terms

["Animals", "Brain Neoplasms", "Cell Differentiation", "Cell Line, Tumor", "Female", "Gene Expression Regulation, Neoplastic", "Genetic Engineering", "Genome", "Glioblastoma", "Glioma", "Humans", "Mice", "Mice, SCID", "Mutation", "Neoplasm Transplantation", "Neoplastic Stem Cells", "Neurofibromin 1", "PTEN Phosphohydrolase", "Pluripotent Stem Cells", "Transplantation, Heterologous", "Tumor Suppressor Protein p53"]

Funding

P30 CA023100 NCI NIH HHS (United States)
T32 GM145427 NIGMS NIH HHS (United States)
T32 GM008666 NIGMS NIH HHS (United States)
K12 GM068524 NIGMS NIH HHS (United States)
R01 HL137223 NHLBI NIH HHS (United States)
R01 HD085902 NICHD NIH HHS (United States)
R01 GM114362 NIGMS NIH HHS (United States)
R01 NS073831 NINDS NIH HHS (United States)
R01 NS080939 NINDS NIH HHS (United States)

Linked Datasets (2)

GSE133479 GSE via ncbi_elink
GEO

Cancer avatars derived from genetically engineered pluripotent stem cells allow for longitudinal assessment of tumor development

Homo sapiens
12 data files
FileTypeSize
smNPCP21C21_S2_L002_R1_001.fastq.gz RNA-Seq 877.8 MB
smNPCP21C21_S2_L002_R1_001.fastq.gz RNA-Seq 877.8 MB
smNPCP21C21_S2_L003_R1_001.fastq.gz RNA-Seq 878.0 MB
smNPCP21C21_S2_L003_R1_001.fastq.gz RNA-Seq 878.0 MB
smNPCT9A35_S3_L002_R1_001.fastq.gz RNA-Seq 1017.9 MB
smNPCT9A35_S3_L002_R1_001.fastq.gz RNA-Seq 1017.9 MB
smNPCT9A35_S3_L003_R1_001.fastq.gz RNA-Seq 1020.6 MB
smNPCT9A35_S3_L003_R1_001.fastq.gz RNA-Seq 1020.6 MB
smNPCWT_S1_L002_R1_001.fastq.gz RNA-Seq 1.0 GB
smNPCWT_S1_L002_R1_001.fastq.gz RNA-Seq 1.0 GB
smNPCWT_S1_L003_R1_001.fastq.gz RNA-Seq 1.0 GB
smNPCWT_S1_L003_R1_001.fastq.gz RNA-Seq 1.0 GB
GSE133509 GSE via ncbi_elink
GEO

Cancer avatars derived from genetically engineered pluripotent stem cells allow for longitudinal assessment of tumor development

Homo sapiens
28 data files
FileTypeSize
17_1_1C_TK_possorted_genome_bam.bam RNA-Seq 1.6 GB
17_1_1C_TK_possorted_genome_bam.bam RNA-Seq 1.6 GB
17_1_1T_TK_possorted_genome_bam.bam RNA-Seq 4.9 GB
17_1_1T_TK_possorted_genome_bam.bam RNA-Seq 4.9 GB
17_1_2C_TK_possorted_genome_bam.bam RNA-Seq 1.6 GB
17_1_2C_TK_possorted_genome_bam.bam RNA-Seq 1.6 GB
17_1_2T_TK_possorted_genome_bam.bam RNA-Seq 5.3 GB
17_1_2T_TK_possorted_genome_bam.bam RNA-Seq 5.3 GB
17_1_3C_TK_possorted_genome_bam.bam RNA-Seq 1.3 GB
17_1_3C_TK_possorted_genome_bam.bam RNA-Seq 1.3 GB
17_1_3T_TK_possorted_genome_bam.bam RNA-Seq 6.7 GB
17_1_3T_TK_possorted_genome_bam.bam RNA-Seq 6.7 GB
17_2_1C_TK_possorted_genome_bam.bam RNA-Seq 13.9 GB
17_2_1C_TK_possorted_genome_bam.bam RNA-Seq 13.9 GB
17_2_1T_TK_possorted_genome_bam.bam RNA-Seq 1.7 GB
17_2_1T_TK_possorted_genome_bam.bam RNA-Seq 1.7 GB
17_2_2C_TK_possorted_genome_bam.bam RNA-Seq 11.3 GB
17_2_2C_TK_possorted_genome_bam.bam RNA-Seq 11.3 GB
17_2_2T_TK_possorted_genome_bam.bam RNA-Seq 1.9 GB
17_2_2T_TK_possorted_genome_bam.bam RNA-Seq 1.9 GB
17_2_3C_TK_possorted_genome_bam.bam RNA-Seq 12.0 GB
17_2_3C_TK_possorted_genome_bam.bam RNA-Seq 12.0 GB
17_2_3T_TK_possorted_genome_bam.bam RNA-Seq 3.7 GB
17_2_3T_TK_possorted_genome_bam.bam RNA-Seq 3.7 GB
3_5_1C_TK_possorted_genome_bam.bam RNA-Seq 5.0 GB
3_5_1C_TK_possorted_genome_bam.bam RNA-Seq 5.0 GB
3_7_1C_TK_possorted_genome_bam.bam RNA-Seq 10.9 GB
3_7_1C_TK_possorted_genome_bam.bam RNA-Seq 10.9 GB

Analysis Pipelines (2)

RNA-seq geo_data_processing GSE133479
geo_data_processing GSE133509